| Company Name
Under Armor (UA) |
Student Name
|
||
| Key Issues | 1. | 2. | 3. |
| Value Proposition
|
|||
| Corporate Strategy | Growth | Pause | Retrenchment |
| Business Strategy | Cost Leader | Differentiation | Focus |
| Functional Strategies | |||
| External Analysis | |||
| PEST | Political/Legal | ||
| Economic | |||
| Social | |||
| Technological/Environmental | |||
| Overall Fav/Unf | |||
| Porter’s 5(+) Forces | Strong | Moderate | Weak |
| Competitors | |||
| New Entrants | |||
| Substitutes | |||
| Suppliers | |||
| Buyers | |||
| Other | |||
| Overall LTPP | |||
| Industry Assessment | |||
| Industry | Primary
|
Secondary
|
|
| Life Cycle | Growth | Maturity | Decline |
| KSFs | |||
| Internal Analysis | |||
| Strengths | |||
| Weaknesses | |||
| Opportunities | |||
| Threats | |||
| Financial Analysis | |||
| Under Armour (UA) | 20xx | 20xx | 20xx |
| Current Ratio | |||
| Debt/Equity Ratio | |||
| Inventory Turns | |||
| Revenue Growth % | |||
| Gross Profit Margin % | |||
| S,G&A % | |||
| Net Profit Margin % | |||
| Nike (NKE) or Columbia (COLM) or Lulemon (LULU) | 20xx | 20xx | 20xx |
| Current Ratio | |||
| Debt/Equity Ratio | |||
| Inventory Turns | |||
| Revenue Growth % | |||
| Gross Profit Margin % | |||
| S,G&A % | |||
| Net Profit Margin % | |||
| Overall Financial Health
|
|||
| IDEA GENERATION | ||||
| Opportunities | Threats | |||
|
Strengths
|
Apply Strengths to Opportunities
|
Apply Strengths to minimize Threats
|
||
|
Weaknesses
|
Minimize Weaknesses with Opportunities
|
Minimize Weaknesses and Threats
|
||
| OPTIONS | ||||
| Description | Pros | Cons | ||
| Option 1 | ||||
| Option 2 | ||||
| Option 3 | ||||
| RECOMMENDATION/IMPACT | ||||
| Idea à Impact | Year 1 | Year 2 | Year 3 | |
Grading Rubric
|
Description |
Possible Points | Actual Points |
Comments |
| Key Issues/Value Proposition | 5 | ||
| Strategy (Corporate/Business/Functional) | 5 | ||
| External Analysis | 10 | ||
| Industry Analysis | 10 | ||
| Internal Analysis | 10 | ||
| Financial Analysis | 10 | ||
| Options | 30 | ||
| Recommendations/Impact | 20 | ||
| TOTAL | 100 |
